Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A adenosine receptors in human renal cells: implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Biochimica et Biophysica Acta - Molecular Basis of Disease Année : 2009

Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A adenosine receptors in human renal cells: implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells

Gianluca Aguiari
  • Fonction : Auteur
Katia Varani
  • Fonction : Auteur
Marco Bogo
  • Fonction : Auteur
Alessandra Mangolini
  • Fonction : Auteur
Fabrizio Vincenzi
  • Fonction : Auteur
Chiara Durante
  • Fonction : Auteur
Stefania Gessi
  • Fonction : Auteur
Valeria Sacchetto
  • Fonction : Auteur
Luigi Catizone
  • Fonction : Auteur
Peter Harris
  • Fonction : Auteur
Rosario Rizzuto
  • Fonction : Auteur
Pier Andrea Borea
  • Fonction : Auteur
Laura del Senno
  • Fonction : Auteur correspondant
  • PersonId : 871722

Connectez-vous pour contacter l'auteur

Résumé

Cyst growth and expansion in autosomal dominant polycystic kidney disease (ADPKD) has been attributed to numerous factors, including ATP, cAMP and adenosine signalling. Although the role of ATP and cAMP has been widely investigated in PKD1-deficient cells, no information is currently available on adenosine-mediated signalling. Here we investigate for the first time the impact of abnormalities of polycystin-1 (PC1) on the expression and functional activity of adenosine receptors, members of the G-protein-coupled receptor superfamily. Pharmacological, molecular and biochemical findings show that a siRNA-dependent PC1-depletion in HEK293 cells and a PKD1-nonsense mutation in cyst-derived cell lines result in increased expression of the A adenosine receptor via an NFkB-dependent mechanism. Interestingly, A adenosine receptor levels result higher in ADPKD than in normal renal tissues. Furthermore, the stimulation of this receptor subtype with the selective agonist Cl-IB-MECA causes a reduction in both cytosolic cAMP and cell proliferation in both PC1-deficient HEK293 cells and cystic cells. This reduction is associated with increased expression of p21 and reduced activation not only of ERK1/2, but also of S6 kinase, the main target of mTOR signaling. In the light of these findings, the ability of Cl-IB-MECA to reduce disease progression in ADPKD should be further investigated. Moreover, our results suggest that NFkB, which is markedly activated in PC1-deficient and cystic cells, plays an important role in modulating AAR expression in cystic cells.
Fichier principal
Vignette du fichier
PEER_stage2_10.1016%2Fj.bbadis.2009.03.001.pdf (612.59 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-00488807 , version 1 (03-06-2010)

Identifiants

Citer

Gianluca Aguiari, Katia Varani, Marco Bogo, Alessandra Mangolini, Fabrizio Vincenzi, et al.. Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A adenosine receptors in human renal cells: implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells. Biochimica et Biophysica Acta - Molecular Basis of Disease, 2009, 1792 (6), pp.531. ⟨10.1016/j.bbadis.2009.03.001⟩. ⟨hal-00488807⟩

Collections

PEER
64 Consultations
180 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More